Siga Technologies (SIGA)
(Real Time Quote from BATS)
$7.36 USD
-0.08 (-1.08%)
Updated May 31, 2024 09:48 AM ET
4-Sell of 5 4
A Value A Growth B Momentum A VGM
Brokerage Reports
0 items in cart
Siga Technologies Inc. [SIGA]
Reports for Purchase
Showing records 61 - 77 ( 77 total )
Company: Siga Technologies Inc.
Industry: Medical - Drugs
GAO Protest Withdrawn - 12 Million Course Option Removed for Now; We Expect Another RFP for Additional Courses of Smallpox Medical Countermeasure
Provider: WEDBUSH SECURITIES INC.
Analyst: WADE G
Company: Siga Technologies Inc.
Industry: Medical - Drugs
Congressional Investigation Fishing Expedition As ST-246 Only Game In Town
Provider: WEDBUSH SECURITIES INC.
Analyst: WADE G
Company: Siga Technologies Inc.
Industry: Medical - Drugs
Company: Siga Technologies Inc.
Industry: Medical - Drugs
First Commercial Sales ST-246 Potentially Before H2:12, Protest To Be Potentially Settled Within 100 Days
Provider: WEDBUSH SECURITIES INC.
Analyst: WADE G
Company: Siga Technologies Inc.
Industry: Medical - Drugs
SIGA Signs BARDA Contract for ST-246; Raising Fair Value PT to $23 from $17
Provider: WEDBUSH SECURITIES INC.
Analyst: WADE G
Company: Siga Technologies Inc.
Industry: Medical - Drugs
Q1:11 Update - Dengue Program Starts, Company Tight- Lipped About Contract Details
Provider: WEDBUSH SECURITIES INC.
Analyst: WADE G
Company: Siga Technologies Inc.
Industry: Medical - Drugs
BARDA announces intent to award SIGA contract for ST-246 for the treatment of Small Pox
Provider: WEDBUSH SECURITIES INC.
Analyst: WADE G
Company: Siga Technologies Inc.
Industry: Medical - Drugs
Company: Siga Technologies Inc.
Industry: Medical - Drugs
Company: Siga Technologies Inc.
Industry: Medical - Drugs
April 2011 Potential Milestones & Key Events - Monthly Update
Provider: WEDBUSH SECURITIES INC.
Analyst: WADE G
Company: Siga Technologies Inc.
Industry: Medical - Drugs
The Week Ahead in Life Sciences - Upcoming Events for the Week of March 27
Provider: WEDBUSH SECURITIES INC.
Company: Siga Technologies Inc.
Industry: Medical - Drugs
Strong 4Q10; Results Confirm Good Market Momentum, and Getting Better; Maintain OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Analyst: WADE G
Company: Siga Technologies Inc.
Industry: Medical - Drugs
Q4:10 Financial Results and Update; Increasing Fair Value Estimate to $17 from $15
Provider: WEDBUSH SECURITIES INC.
Analyst: WADE G
Company: Siga Technologies Inc.
Industry: Medical - Drugs
Highlights from Our Call on the Ongoing SIGA-PIP Litigation
Provider: WEDBUSH SECURITIES INC.
Analyst: WADE G
Company: Siga Technologies Inc.
Industry: Medical - Drugs
Company: Siga Technologies Inc.
Industry: Medical - Drugs
Company: Siga Technologies Inc.
Industry: Medical - Drugs
Initiating research coverage with an OUTPERFORM rating and fair value of $15/share.
Provider: WEDBUSH SECURITIES INC.
Analyst: WADE G